BIOATLA, INC. (BCAB) Quick Ratio
- Quick ratio · latest quarter: Value (m); Formula and calculation Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30..
Quick ratio
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Quick ratio · latest quarter | (m) | Cash, cash equivalents, current marketable securities and trade receivables / current liabilities. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Cash, securities and trade receivables | (m) | Cash and Cash Equivalents, at Carrying Value · Accounts Receivable, after Allowance for Credit Loss, Current |
| Current obligations | 21.02M USD | Liabilities, Current |
| Cash and equivalents | 1.54M USD | Cash and Cash Equivalents, at Carrying Value |
| Short-term securities | (m) | |
| Customer receivables | 2.00M USD | Accounts Receivable, after Allowance for Credit Loss, Current |
| Inventory · excluded from quick assets | (m) |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Cash, securities and trade receivables (USD) | Current obligations (USD) | Cash and equivalents (USD) | Short-term securities (USD) | Customer receivables (USD) | Inventory · excluded from quick assets (USD) | Quick ratio |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | (m) | $21.02M | $1.54M | (m) | $2.00M | (m) | (m) |
| 2026-03-31 | (m) | $20.69M | $1.96M | (m) | (m) | (m) | (m) |
| 2025-12-31 | (m) | $21.92M | $7.12M | (m) | (m) | (m) | (m) |
| 2025-09-30 | (m) | $17.98M | $8.32M | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | $16.60M | $18.21M | (m) | (m) | (m) | (m) |
| 2025-03-31 | (m) | $16.01M | $32.36M | (m) | (m) | (m) | (m) |
| 2024-12-31 | (m) | $14.54M | $49.05M | (m) | (m) | (m) | (m) |
| 2024-09-30 | (m) | $19.46M | $56.52M | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | $17.46M | $61.66M | (m) | (m) | (m) | (m) |
| 2024-03-31 | (m) | $19.26M | $80.63M | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | $28.34M | $111.47M | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | $35.60M | $141.28M | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | $33.65M | $168.69M | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | $26.26M | $192.69M | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | $23.13M | $215.51M | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | $23.82M | $178.12M | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | $25.51M | $202.29M | (m) | (m) | (m) | (m) |
| 2022-03-31 | (m) | $17.19M | $219.43M | (m) | (m) | (m) | (m) |
| 2021-12-31 | (m) | $19.81M | $244.98M | (m) | (m) | (m) | (m) |
| 2021-09-30 | (m) | $45.23M | $269.93M | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | $36.16M | $207.61M | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | $30.53M | $221.20M | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | $32.26M | $238.60M | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | $56.76M | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | $184.00K | (m) | (m) | (m) | (m) |
| 2020-03-31 | (m) | (m) | $370.00K | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | $3.70M | (m) | (m) | (m) | (m) |
| 2018-12-31 | (m) | (m) | $10.86M | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |